type here...

CATEGORIES

Breaking Research

LATEST

1234Page 2 of 4

TRENDING

EDITORS CHOICE

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Covid: Why You Need a Booster

Michael Hunter, MD -
THE BAD NEWS? ALL THREE of the COVID-19 vaccines approved in the United States seem to be significantly less protective against the new Omicron variant...

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

Got Cancer? Supplements May Be Dangerous

Michael Hunter, MD -
IF YOU HAVE CANCER, there is a reasonable chance that you are taking supplements. The use of dietary supplements in the United States is widespread....

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories